Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Human hair follicles have a unique metabolism that changes between growth stages and may contribute to baldness.

Many elderly women experience unwanted facial hair and various hair loss conditions, with treatments available for each condition.

Eye exams are crucial for kids with 13q deletion syndrome, tamoxifen can cause vision loss, Propecia may lead to cataracts, Lipoid Proteinosis causes skin bumps, and OCT is useful for diagnosing macular diseases.

Androgen excess disorders in women were effectively treated with spironolactone, estrogen, and dexamethasone.

Some skin medications can harm male fertility, but they don't seem to cause birth defects from father's exposure.

COVID-19 may harm male fertility and damage the reproductive system.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

Older adults have a wide range of skin conditions, with dry skin being very common and many also experiencing skin growths, itching, and infections.

The postnatal thymus has cells like mesenchymal stem cells that can become different cell types and help maintain thymus structure.

New treatments for skin conditions related to the sebaceous gland are being developed based on current research.

Over 50% of women over 50 experience hair loss, with minoxidil being the only proven effective treatment.

Hormone imbalances can cause skin diseases, and understanding these links is important for diagnosis and treatment.

Blocking enzymes that help the virus enter cells could be a promising way to treat COVID-19.

Finasteride effectively treats central serous chorioretinopathy.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

A baby boy with 13q deletion syndrome had eye cancer, a woman's vision improved after stopping a breast cancer drug, a man developed cataracts from using Propecia, and a rare skin disorder called Lipoid Proteinosis was discussed. Also, a tool called OCT is useful for diagnosing macular diseases.

Taking Propecia might lead to the development of cataracts.

The document discusses various eye conditions and their treatments, including a rare eye cancer in a baby, vision loss from a cancer drug, cataracts from a baldness treatment, a rare skin disorder, and a specific type of eye disease diagnosed with a special imaging technique.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

Androgenic Alopecia, a common hair loss condition, can be effectively treated with finasteride and other treatments.

Progesterone treatment improved seizures in a woman with menstrual cycle-related epilepsy, but a wrong medication worsened her condition.

Male pattern baldness may be caused by factors like poor blood circulation, scalp tension, stress, and hormonal imbalances, but the exact causes are still unclear.

Finasteride, often used for hair loss, can potentially cause cataracts.

COVID-19 may worsen with androgens; anti-androgen drugs could help.

The document concludes that careful diagnosis is crucial for chromosome 13q deletion syndrome, tamoxifen can cause reversible eye damage, finasteride may be linked to cataracts, and OCT is useful for diagnosing macular diseases.

Higher DHT levels are linked to fewer hypogonadism symptoms in men with normal testosterone levels.

Phthirusa pyrifolia extract may lower testosterone and harm male rat reproduction without damaging the liver or kidneys.

Multiple eye conditions were studied, highlighting the importance of various imaging methods for diagnosis, the vision side effects of drugs tamoxifen and Propecia, and the usefulness of optical coherence tomography for diagnosing and monitoring macular and retinal diseases.

No treatment is clearly better for central serous chorioretinopathy, and more research is needed.